Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16 - XML Representation

Raw xml | Download



<ArtifactAssessment xmlns="http://hl7.org/fhir">
  <id value="179698"/>
  <meta>
    <versionId value="4"/>
    <lastUpdated value="2023-12-06T08:41:24.889Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"/>
  </meta>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ArtifactAssessment</b><a name="179698"> </a><a name="hc179698"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">ResourceArtifactAssessment &quot;179698&quot; Version &quot;4&quot; Updated &quot;2023-12-06 08:41:24+0000&quot; </p><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-adaptation.html">Adaptation</a></p></div><p><b>Artifact Author</b>: Joanne Dehnbostel: </p><p><b>Artifact URL</b>: <a href="https://fevir.net/resources/ArtifactAssessment/179698">https://fevir.net/resources/ArtifactAssessment/179698</a></p><p><b>Artifact Description</b>: This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data.</p><blockquote><p><b>modifierExtension[http://hl7.org/fhir/StructureDefinition/artifact-status]</b></p></blockquote><p><b>identifier</b>: FEvIR Object Identifier/179698</p><p><b>title</b>: Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16</p><p><b>artifact</b>: <a href="Composition-179466.html">Composition/179466: Recommendation: ADA Obesity Management Recommendation 8.16</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: container</p><p><b>type</b>: adapted element <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></p><p><b>classifier</b>: string Datatype <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#string-datatype)</span></p><p><b>path</b>: <code>overallSummary</code></p><h3>Components</h3><table class="grid"><tr><td style="display: none">-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td></tr><tr><td style="display: none">*</td><td>comment</td><td>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A</td><td>Original Resource Content <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#OriginalResourceContent)</span></td><td> </td></tr><tr><td style="display: none">*</td><td>response</td><td> </td><td>Rationale for Change to Resource Content <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#RationaleForChange)</span></td><td>Suggested change <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#suggested-change)</span></td></tr><tr><td style="display: none">*</td><td>change-request</td><td>8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.</td><td>Suggested Change to Resource Content <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-179423.html">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#SuggestedChange)</span></td><td> </td></tr></table></blockquote></div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Joanne Dehnbostel"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-url">
    <valueUri value="https://fevir.net/resources/ArtifactAssessment/179698"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/artifact-description">
    <valueMarkdown
                   value="This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."/>
  </extension>
  <modifierExtension
                     url="http://hl7.org/fhir/StructureDefinition/artifact-status">
    <valueCode value="active"/>
  </modifierExtension>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net"/>
    <value value="179698"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <title
         value="Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16"/>
  <artifactReference>🔗 
    <reference value="Composition/179466"/>
    <type value="Composition"/>
    <display
             value="Recommendation: ADA Obesity Management Recommendation 8.16"/>
  </artifactReference>
  <content>
    <informationType value="container"/>
    <type>
      <text value="adapted element"/>
    </type>
    <classifier>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="string-datatype"/>
        <display value="string Datatype"/>
      </coding>
    </classifier>
    <path value="overallSummary"/>
    <component>
      <informationType value="comment"/>
      <summary
               value="8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A"/>
      <type>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="OriginalResourceContent"/>
          <display value="Original Resource Content"/>
        </coding>
      </type>
    </component>
    <component>
      <informationType value="response"/>
      <type>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="RationaleForChange"/>
          <display value="Rationale for Change to Resource Content"/>
        </coding>
      </type>
      <classifier>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="suggested-change"/>
          <display value="Suggested change"/>
        </coding>
      </classifier>
    </component>
    <component>
      <informationType value="change-request"/>
      <summary
               value="8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI ≥40 kg/m2 (BMI ≥37.5 kg/m2 in Asian Americans) and in adults with BMI 35.0–39.9 kg/m2 (32.5–37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods."/>
      <type>
        <coding>
          <system value="https://fevir.net/resources/CodeSystem/179423"/>
          <code value="SuggestedChange"/>
          <display value="Suggested Change to Resource Content"/>
        </coding>
      </type>
    </component>
  </content>
</ArtifactAssessment>